Discover Heru's New Fast Pattern Suprathreshold Visual Field!
Dark Adaptation has arrived!

DARK ADAPTATION HAS ARRIVED!

Dark Adaptation Arrives in

Days
Hours
Minutes
Seconds

Dark Adaptation Arrives in

Days
Hours
Minutes
Seconds
Discover Heru's New Fast Pattern Suprathreshold Visual Field!

Heru Company Bios

Mohamed Abou Shousha, MD, PhD

Founder, President, and CEO

Mohamed Abou Shousha, MD, PhD is Heru’s President and Chief Executive Officer. Dr. Abou Shousha is a practicing ophthalmologist at the University of Miami’s Bascom Palmer Eye Institute, where he serves as Associate Professor of Clinical Ophthalmology, Electrical and Computer Engineering, and Biomedical Engineering.

He and his team of clinicians and engineers spent over ten years conducting clinical and scientific research of ophthalmic imaging and artificial intelligence (AI) algorithms that led to Heru AI powered wearable device. His work has been published in leading peer reviewed ophthalmology journals. In addition to other prestigious awards, Dr. Abou Shousha was awarded multi-million dollars R01 and K23 awards from the National Eye Institute, the Stanley J. Glaser Award, the American Academy of Ophthalmology Achievement Award, Achievement Award of the Association of University Professor of Ophthalmology (AUPO) and the 6 Best Paper of Session award of the American Society of Cataract and Refractive Surgery (ASCRS).

Dr. Abou Shousha received his medical degree from the Faculty of Medicine, Alexandria University, Egypt, and completed his residency at St. Louis University Eye Institute. He completed a fellowship in cornea, refractive surgery, and external eye disease at the University of Miami, Bascom Palmer Eye Institute. He holds a doctoral degree in ophthalmology and vision sciences from the Supreme Council of Universities of Egypt and a fellowship from the royal college of surgeons of Glasgow University.

Fred Drasner

Board Member

Chairman of Three Seasons Capital, LLC, a venture capital firm.Mr. Drasner, with a partner, acquired U. S. News &World Report and served as its CEO and Co-Chairman from 1985 to 2004. In 1993, they acquired the New York Daily News and he remained co-owner, Chief Executive Officer and Co-Publisher until 2004. Mr. Drasner founded Fast Company Magazine in 1995 and served as CEO until its sale 1999. In 1985, he started Applied Graphics Technologies, took it public in 1996 (NASDAQ), and served as its Chairman and CEO from 1985 until its sale in 2003. During that period, it grew into the world’s largest Digital Image Management Company

He was an initial investor in Snyder Communications (NYSE) and a board member until its sale to Havas for $2.3 billion in 1999. He was co-owner and Vice Chairman of The Washington Redskins football team from 1999 to 2004. Mr. Drasner was the founder of the Vehicle Production Group in 2007 and served as its chairman until its sale in 2013.

Richard K. Parrish II, MD

Board Member

Richard K. Parrish II, MD is a world-renown glaucoma specialist and is the Edward W.D. Norton Chair in Ophthalmology and Associate Dean for Graduate Medical Education ot the University of Miami Miller School of Medicine.  he also serves as Chairman of the Graduate Medical Education Committee and is the designated institutional representative for the Jackson Health System/Jackson Memorial Hospital.

Kerri-Lynn Primmer Morris

Board Member

Kerri-Lynn is the former Chief Technology Officer for Healthcare and Life Sciences for Microsoft Industry Solutions.  She serves as an advisor in the Mixed Reality and connected IoT space and is passionate about AR/VR/MR and IoT’s potential to healthcare.  Kerri-Lynn also previously held an executive role at Kaiser Permanente focused on driving the success of transformational programs.

Rajesh Rajpal, MD

Board Member

Rajesh Rajpal, MD is the Founder of See Clearly Vision, a group practice in the Washington, D.C. Area. He previously served as Chief Medical Officer for Avedro (acquired by Glaukos) and is Chief Medical Officer and Global Head of Clinical and Medical Affairs at Johnson & Johnson Vision.

Expanding Clinical Care for AMD ​

Heru’s Dark Adaptation Fills the Gap

To learn more download the white paper below.